Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

815 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report.
Matsumura Y, Ichihara S, Nii K, Nanjo K, Kadota N, Okano Y, Machida H, Hatakeyama N, Hino H, Naruse K, Shinohara T, Sakiyama S, Takeuchi E. Matsumura Y, et al. Among authors: okano y. Thorac Cancer. 2025 Jan;16(2):e15519. doi: 10.1111/1759-7714.15519. Epub 2024 Dec 17. Thorac Cancer. 2025. PMID: 39688181 Free PMC article.
Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial.
Tamai H, Ikeda K, Miyamoto T, Taguchi H, Kuo CF, Shin K, Hirata S, Okano Y, Sato S, Yasuoka H, Kuwana M, Ishii T, Kameda H, Kojima T, Nishi Y, Mori M, Miyagishi H, Toshima G, Sato Y, Tsai WC, Takeuchi T, Kaneko Y; MIRACLE Study Group; MIRACLE study Group. Tamai H, et al. Among authors: okano y. Ann Rheum Dis. 2024 Oct 4:ard-2024-226350. doi: 10.1136/ard-2024-226350. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39366722
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.
Tsukazaki Y, Ogino H, Okano Y, Kakiuchi S, Harada S, Toyoda Y, Matsumura Y, Ichihara S, Imakura T, Matsumoto R, Ozaki R, Ogawa E, Morita Y, Mitsuhashi A, Yabuki Y, Yoneda H, Hanibuchi M, Hase K, Takeuchi E, Haku T, Nishioka Y. Tsukazaki Y, et al. Among authors: okano y. Int J Clin Oncol. 2024 Oct;29(10):1451-1460. doi: 10.1007/s10147-024-02586-0. Epub 2024 Jul 15. Int J Clin Oncol. 2024. PMID: 39009900
815 results